Updates

Alliance Pharma - Beats expectations again

February 2010

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Shares in speciality pharmaceutical firm, Alliance Pharma soared after it revealed that thanks to strong trading in the final few months of 2009, it now expects to report a 42% rise in turnover to Â£31m. Meanwhile, pretax profit before impairment charges is expected to be no less than Â£8.5m, which is significantly ahead of current market expectations. The strong trading reflects good performances from anti-inflammatory agent, Deltacortril; the aspirin, Nu-Seals; Buccastem for treating nausea; and Timodine, an anti-bacterial skin cream.The impairment charges relate to it pulling the plug on further investment in clinical trials for its developmental drug Isprelor, for the induction of labour, which has a book value of Â£2.8m. This ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Petrofac

Hargreaves

Alliance Pharma (July 2013)

Alliance Pharma - Acquires new products (September 2012)

Alliance Pharma (June 2012)

Alliance Pharma (November 2011)

Alliance Pharma - Cambridge Labs nehind its growth (June 2011)

Alliance Pharma (October 2010)

Alliance Pharma (August 2010)

Alliance Pharma - Trading ahead of expectations (July 2010)

Alliance Pharma - Gain reaches 75% in five months (May 2010)

Alliance Pharma - Substantial eps enhancing acquisition (March 2010)

Alliance Pharma - Branded pharmaceuticals firm going great guns but cheap on PE of 6.7 (December 2009)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X